Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-09-25

FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for mirtazapine from Sun Pharmaceutical Industries, resulting in labeling updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)